1.
2.
PSA doubling times of prostate carcinoma managed with watchful observation alone
by Dunst, J
Strahlentherapie und Onkologie, 2001, Vol.177 (12), p.684-685
3.
Prognostic value of p53 for locoregional recurrence in mastectomy treated breast cancer patients
by Rödel, F
Strahlentherapie und Onkologie, 2000, Vol.176 (12), p.586-587
4.
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom
by Candler, P M
Journal of neurology, neurosurgery and psychiatry, 2004, Vol.75 (10), p.1411-1415
5.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
by Mateo, Joaquin
The lancet oncology, 2020, Vol.21 (1), p.162-174
6.
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
by Leiter, Ulrike, Dr
The lancet oncology, 2016, Vol.17 (6), p.757-767
7.
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results fro...
by Schmid, Peter
The lancet oncology, 2020, Vol.21 (1), p.44-59
8.
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia
by Sabatowski, Rainer
Current medical research and opinion, 2012, Vol.28 (8), p.1337-1346
9.
DDT Exposure in Utero and Breast Cancer
by Cohn, Barbara A
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (8), p.2865-2872
10.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase...
by Seiwert, Tanguy Y, Dr
The lancet oncology, 2016, Vol.17 (7), p.956-965
11.
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
by Antonia, Scott J, Prof
The lancet oncology, 2016, Vol.17 (7), p.883-895
12.
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
by Hellmann, Matthew D, Dr
The lancet oncology, 2016, Vol.18 (1), p.31-41
13.
Musculoskeletal disorders of the neck and shoulders in female sewing machine operators: prevalence, incidence, and prognosis
by Kaergaard, Anette
Occupational and environmental medicine (London, England), 2000, Vol.57 (8), p.528-534
14.
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
by Muro, Kei, Dr
The lancet oncology, 2016, Vol.17 (6), p.717-726
15.
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
by D'Amico, G.
Alimentary pharmacology & therapeutics, 2014, Vol.39 (10), p.1180-1193
16.
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
by Choueiri, Toni K, Dr
The lancet oncology, 2016, Vol.17 (7), p.917-927
17.
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
by Raaschou-Nielsen, Ole, Dr
The lancet oncology, 2013, Vol.14 (9), p.813-822
18.
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
by Rossi, Emma C, MD
The lancet oncology, 2017, Vol.18 (3), p.384-392
19.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, cross...
by Khalaf, Daniel J
The lancet oncology, 2019, Vol.20 (12), p.1730-1739
20.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
by Mima, Kosuke Kosuke
Gut, 2015, Vol.65 (12), p.1973-1980
Filter electronic articles 11.914 Hits
Remove Filters
- Subjects
- Prognosis
- Humans (11.902)
- Follow-Up Studies (11.861)
- more ...